Mayo Medical Laboratories (MML)- Second tier testing for NBS

Mayo Medical Laboratories (MML)- Second tier testing for NBS The Michigan Department of Health and Human Services Bureau of Laboratories (MDHHS-BOL) intends to contract with Mayo Medical Laboratories for second-tier testing of dried blood spots as well as the interpretation of the results as part of newborn screening. Testing must be for specific analytes, including: 17-hydroxyprogesterone, androstenedione, cortisol, 11-deoxycortisol and 21-deoxycortisol for congenital adrenal hyperplasia (CA), Homocysteine (total), methylmalonic acid and methylcitric acid for propionic acidemia, methylmalonic acidemia, homocystinuria, (PA/MMA/HCU), Heparan sulfate and dermatan sulfate for mucopolysaccharidiosis types I, II, III, IV (MPS I, II, III, IV), Creatine, creatinine, and activity of acid-alpha glucosidase for Pompe Disease (PD), Alloisoleucine, leucine, isoleucine and valine for Maple Syrup Urine Disease (MSUD), Hydroxyglutaric Acids, Glutaric Acid, Ethylmalonic Acid and Methylsuccinic Acid for glutaric acidemia, and Lysophosphatidylcholines by Liquid Chromatography-Tandem Mass Spectrometry for X-linked adrenoleukodystrophy (X-ALD). Mayo Medical Laboratories (MML) is the only service provider who conducts these tests on dried blood spots and provides the appropriate methodology and interpretation to meet the needs of the MDHHS laboratory. Commodity lines: - Medical and Laboratory Services (Non-Physician)

• NAICS94855

• ITN 270000000003.docx

  Not yet available

• WANDA RADEMACHER
  rademacherw@michigan.gov517-241-0134